Conflict of interest statement: Disclosure The authors report no conflicts ofinterest in this work.16. Onco Targets Ther. 2018 Apr 11;11:2051-2061. doi: 10.2147/OTT.S162503.eCollection 2018.Combination of SIRT1 and Src overexpression suggests poor prognosis in luminalbreast cancer.Tan J(#)(1), Liu Y(#)(2), Maimaiti Y(3), Wang C(1), Yan Y(1), Zhou J(1), RuanS(1), Huang T(1).Author information: (1)Department of Breast and Thyroid Surgery, Union Hospital, Tongji MedicalCollege, Huazhong University of Science and Technology, Wuhan, China.(2)Department of Clinical Laboratory, Union Hospital, Tongji Medical College,Huazhong University of Science and Technology, Wuhan, China.(3)Department of General Surgery, Research Institute of Minimally Invasive,People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.(#)Contributed equallyObjectives: 1) Analyze the correlation of SIRT1 and Src with human breast cancer (BC) prognosis; 2) explore the roles of SIRT1 and Src in BC cell proliferation,tumor invasion, and metastasis; and 3) analyze the correlation and interactionbetween SIRT1 and Src.Materials and methods: 1) Tissue microarray was used to analyze the expression ofSIRT1 and Src in human BC tissues and the correlation between protein expression and cancer prognosis; 2) CCK8 assay was used to determine the influence of SIRT1 and Src inhibitors on BC cell proliferation; 3) Transwell migration assay andwound healing assay were used to determine the effect of SIRT1 and Src inhibitorson BC cell migration and invasion; and 4) Western blotting was used to analyzethe correlation and interaction between SIRT1 and Src.Results: 1) Combination of SIRT1 and/or Src positivity is a prognosis factor inBC, especially in luminal type; 2) MCF-7 cell proliferation is suppressed bySIRT1 inhibitor Ex527, and cell migration and invasion were inhibited by Srcinhibitor bosutinib; 3) combined with Ex527, bosutinib has a significantlyincreased effect on MCF-7 cell migration suppression; and 4) there is a positive association between SIRT1 and Src both in BC tissues and in MCF-7 cells.Conclusion: 1) SIRT1 and Src overexpression are both correlated with poorprognosis in human BC; 2) SIRT1 + Src (SIRT1 and/or Src positivity) is a fineprognosis model for luminal-type BC; 3) SIRT1 is a copromotor of Src in BCmigration and invasion, but not in cell proliferation; and 4) our results suggesta potential interaction or a common regulation pathway between SIRT1 and Srcexpression and activity.DOI: 10.2147/OTT.S162503 PMCID: PMC5905521PMID: 29695913 